Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherThis Month in JNM

THIS MONTH IN JNM

Journal of Nuclear Medicine October 2005, 46 (10) 8a-9a;
  • Article
  • Info & Metrics
  • PDF
Loading

Schillaci reviews the benefits and current clinical applications of scintimammography and assesses the technological developments that would allow this modality to become a routine adjunct in breast cancer imaging.

Page 1571

Figure

Mathieu and colleagues report on the results of a retrospective study exploring the effect of scintimammography as a complementary tool in the management of patients with inconclusive triple diagnoses (mammography, ultrasound, and fine-needle aspiration cytology) suggesting breast cancer.

Page 1574

Yun and colleagues compare 18F-FDG PET with CT in the evaluation of primary tumors and lymph node metastases in early and advanced gastric cancer and discuss the implications of these findings for the identification of optimal initial therapies.

Page 1582

Elhendy and colleagues investigate whether the presence of ischemia on stress myocardial perfusion imaging is a significant predictor of deaths from all causes during long-term follow-up in patients with diabetes mellitus.

Page 1589

Emmett and colleagues report on clinical factors that may influence the incidence of transient ischemic dilation on myocardial perfusion SPECT, with specific attention to the effects of left ventricular hypertrophy and diabetes.

Page 1596

Stankewicz and colleagues compare the effectiveness of 82Rb washout studies with PET 18F-FDG–82Rb mismatch studies in the accurate assessment of myocar-dial viability in patients with coronary artery disease.

Page 1602

Yaoita and colleagues use myocardial perfusion scintigraphy to evaluate the regenerative effects of autologous bone marrow–derived mononuclear cell transplantation into ischemic myocardium in patients who undergo off-pump coronary artery bypass surgery.

Page 1610

Freedman and colleagues assess the ability of 11C-l-deprenyl PET to demonstrate the specific binding characteristics of the novel irreversible selective monoamine oxidase B inhibitor rasagiline, which may have beneficial applications in the treatment of early-stage Parkinson’s disease.

Page 1618

Drzezga and colleagues report on a longitudinal study designed to determine the combined value of genotyping and 18F-FDG PET assessment of cerebral glucose metabolism in the early diagnosis of Alzheimer’s type dementia in patients with mild cognitive impairment.

Page 1625

Figure

Chen and colleagues describe and validate a rapid 18F-FDG PET brain imaging protocol and compare it with conventional protocols in assessing glucose metabolism in patients with and without Alzheimer’s disease.

Page 1633

Farsad and colleagues evaluate the potential usefulness of 11C-choline PET/CT for detection and localization of tumors within the prostate and compare these imaging findings with histopathologic results.

Page 1642

Figure

Installé and colleagues assess the ability of 18F-fluoride PET to monitor therapeutic response to bisphosphonates in patients with Paget’s disease and discuss the implications for routine use of whole-body PET for this purpose.

Page 1650

Wong and colleagues report on a study designed to derive an optimal glucose sensitivity factor and most discriminating standardized uptake value normalized to glucose for the use of 18F-FDG PET in classifying indolent and aggressive lymphomas.

Page 1659

Schwaiger and colleagues review current challenges and potential for PET/CT in the routine characterization of coronary artery disease and speculate on future clinical applications in cardiology.

Page 1664

Jönsson and colleagues simulate scintillation camera images of patients and evaluate the accuracy of 2 methods designed to minimize the confounding effects of scattered radiation from adjacent organs and activity from overlapping tissues.

Page 1679

Figure

Lee and colleagues describe a noninvasive, fast, and accurate method for estimating myocardial blood flow and generating a parametric image using a novel linear least-squares estimation technique and H215O dynamic myocardial PET.

Page 1687

de Jong and colleagues use 111In-DTPA-octreotide SPECT in mice to investigate the role of megalin in renal tubular reabsorption of radiolabeled somatostatin ana-logs, with implications for tumor diagnosis and radionuclide therapy.

Page 1696

Chéhadé and colleagues apply secondary ion mass spectrometry to obtain quantitative and qualitative data on the biodistribution of a 14C-labeled melanoma-targeting molecule in mice and discuss the potential for this technique in molecular analysis of radiopharmaceutical action and distribution.

Page 1701

Wu and colleagues investigate a novel 64Cu-labeled tetrameric RGD peptide tracer with promise for PET imaging of integrin αvβ3 expression in solid tumors and as a therapeutic radiopharmaceutical in integrin-positive tumors.

Page 1707

Mathews and colleagues synthesize and evaluate in a mouse model a positron-emitting analog of a nuclear receptor that plays a central role in the control of lipid and glucose metabolism.

Page 1719

Nock and colleagues evaluate 3 new modified 99mTc-labeled minigastrin analogs in both in vitro and animal models for their suitability in cholecystokinin subtype 2/gastrin receptor–targeted imaging of tumors.

Page 1727

Pan and colleagues investigate a method for improving the consistency of analysis in 18F-FDOPA PET images obtained to assess the diminished functionality of the striatum in patients with suspected Parkinson’s disease.

Page 1737

Chan and colleagues describe the synthesis of a novel radiolabeled recombinant vascular endothelial growth factor receptor–binding protein for imaging tumor angiogenesis.

Page 1745

Lee and colleagues study differential glucose uptake and transport patterns in hepatocellular carcinomas and cholangiocarcinomas and discuss the potential roles of tumor-suppressor genes in these differences as well as implications for 18F-FDG PET imaging of oncogenic variations.

Page 1753

ON THE COVER

At top, nodular HCC in the inferior segment of the right lobe of the liver shows increased 18F-FDG uptake on PET. Immunohistochemical staining shows a negative reaction for Glut 1 but a positive reaction for hexokinase type II (HK II). At bottom, a mass-forming cholangiocarcinoma in the inferior segment of the right lobe of the liver shows intense 18F-FDG uptake. Pathologically, the tumor shows a strong positive reaction for Glut 1 along the cell membrane but a negative reaction for HK II.

Figure
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (10)
Journal of Nuclear Medicine
Vol. 46, Issue 10
October 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
THIS MONTH IN JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
THIS MONTH IN JNM
Journal of Nuclear Medicine Oct 2005, 46 (10) 8a-9a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
THIS MONTH IN JNM
Journal of Nuclear Medicine Oct 2005, 46 (10) 8a-9a;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Is There a Clinical Role for Scintimammography in Breast Cancer Diagnosis?
  • Inconclusive Triple Diagnosis in Breast Cancer Imaging: Is There a Place for Scintimammography?
  • Lymph Node Staging of Gastric Cancer Using 18F-FDG PET: A Comparison Study with CT
  • Association of Ischemia on Stress99mTc-Tetrofosmin Myocardial Perfusion Imaging with All-Cause Mortality in Patients with Diabetes Mellitus
  • The Role of Left Ventricular Hypertrophy and Diabetes in the Presence of Transient Ischemic Dilation of the Left Ventricle on Myocardial Perfusion SPECT Images
  • Myocardial Viability Assessment by PET: 82Rb Defect Washout Does Not Predict the Results of Metabolic–Perfusion Mismatch
  • Scintigraphic Assessment of the Effects of Bone Marrow–Derived Mononuclear Cell Transplantation Combined with Off-Pump Coronary Artery Bypass Surgery in Patients with Ischemic Heart Disease
  • In Vivo Measurement of Brain Monoamine Oxidase B Occupancy by Rasagiline, Using 11C-l-Deprenyl and PET
  • Prediction of Individual Clinical Outcome in MCI by Means of Genetic Assessment and 18F-FDG PET
  • Rapid Scanning Protocol for Brain 18F-FDG PET: A Validation Study
  • Detection and Localization of Prostate Cancer: Correlation of 11C-Choline PET/CT with Histopathologic Step-Section Analysis
  • 18F-Fluoride PET for Monitoring Therapeutic Response in Paget’s Disease of Bone
  • Glucose-Normalized Standardized Uptake Value from 18F-FDG PET in Classifying Lymphomas
  • PET/CT: Challenge for Nuclear Cardiology
  • Evaluation of Accuracy in Activity Calculations for the Conjugate View Method from Monte Carlo Simulated Scintillation Camera Images Using Experimental Data in an Anthropomorphic Phantom
  • Generation of Parametric Image of Regional Myocardial Blood Flow Using H215O Dynamic PET and a Linear Least-Squares Method
  • Megalin Is Essential for Renal Proximal Tubule Reabsorption of 111In-DTPA-Octreotide
  • Secondary Ion Mass Spectrometry as a Tool for Investigating Radiopharmaceutical Distribution at the Cellular Level: The Example of I-BZA and 14C-I-BZA
  • microPET Imaging of Glioma Integrin αvβ3 Expression Using 64Cu-Labeled Tetrameric RGD Peptide
  • Synthesis and Biodistribution of 11C-GW7845, a Positron-Emitting Agonist for Peroxisome Proliferator–Activated Receptor-γ
  • CCK-2/Gastrin Receptor–Targeted Tumor Imaging with 99mTc-Labeled Minigastrin Analogs
  • Improving Influx Constant and Ratio Estimation in FDOPA Brain PET Analysis for Parkinson’s Disease
  • A Human Transferrin-Vascular Endothelial Growth Factor (hnTf-VEGF) Fusion Protein Containing an Integrated Binding Site for 111In for Imaging Tumor Angiogenesis
  • Different Glucose Uptake and Glycolytic Mechanisms Between Hepatocellular Carcinoma and Intrahepatic Mass-Forming Cholangiocarcinoma with Increased 18F-FDG Uptake
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire